Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription 26.05.2025 1 Brain 1 Curr Opin Immunol 2 Diabet Med 6 Diabetes 12 Diabetes Res Clin Pract 7 J Clin Endocrinol Metab 1 J Immunol 3 J Neuroimmunol 5 J Neurol 5 Mult Scler 5 PLoS One 2 Proc Natl Acad Sci U S A 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Brain

1. IRANI SR
   Models of autoantibody mediated diseases: actively nearing the human gold standard.
   Brain. 2025 May 23:awaf160. doi: 10.1093.
   PubMed        
   
   

   
   Curr Opin Immunol

2. GUVENC F, Danska JS
   The intestinal microbiome in type 1 diabetes: bridging early childhood exposures with translational advances.
   Curr Opin Immunol. 2025;94:102553.
   PubMed         Abstract available
   
   

   
   Diabet Med

3. SWABY R, Randell T, Bowen-Morris J, Dayan C, et al
   A UK healthcare professional survey on the islet autoantibody status of children and young people with pre-stage 3 type 1 diabetes, on behalf of the British Society for Paediatric Endocrinology and Diabetes.
   Diabet Med. 2025 May 23:e70069. doi: 10.1111/dme.70069.
   PubMed        
   
   
4. FAUSTINI SE, Quinn LM, Hoque M, Young S, et al
   Establishing the performance and acceptability of dried blood spot sampling to screen for islet-specific autoantibodies.
   Diabet Med. 2025 May 19:e70071. doi: 10.1111/dme.70071.
   PubMed         Abstract available
   
   

   
   Diabetes

5. AKHBARI P, Perez-Hernandez J, Russell MA, Dhayal S, et al
   Soluble HLA Class I Is Released From Human beta-Cells Following Exposure to Interferons.
   Diabetes. 2025;74:956-968.
   PubMed         Abstract available
   
   
6. WATSON TK, Rosen ABI, Drow T, Medjo JA, et al
   Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell-Intrinsic Immune Tolerance.
   Diabetes. 2025;74:943-955.
   PubMed         Abstract available
   
   
7. LEE J, Ustione A, Wilkerson EM, Balakrishnan R, et al
   Regulation of Type 1 Diabetes via Brown Adipocyte-Secreted Proteins and the Novel Glucagon Regulator Nidogen-2.
   Diabetes. 2025 Feb 28:db241003. doi: 10.2337/db24-1003.
   PubMed         Abstract available
   
   
8. THOMSON EA, Lee S, Xu H, Moeller H, et al
   Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics.
   Diabetes. 2025;74:873-884.
   PubMed         Abstract available
   
   
9. MCNITT DH, Williams JM, Santitoro JG, Kim J, et al
   Type 1 diabetes depends on CD4-driven expression of the transcriptional repressor, Bcl6.
   Diabetes. 2024 Nov 18:db230709. doi: 10.2337/db23-0709.
   PubMed         Abstract available
   
   
10. BRUCE CR, Ang T, Toms JD, Dao GM, et al
    The Effect of Small Increases in Blood Glucose on Insulin Secretion and Endogenous Glucose Production in Humans.
    Diabetes. 2025;74:898-906.
    PubMed         Abstract available
    
    

    
    Diabetes Res Clin Pract

11. TUMMINIA A, Santoro GM, Oteri V, Galeano F, et al
    The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy.
    Diabetes Res Clin Pract. 2025;224:112173.
    PubMed         Abstract available
    
    
12. AZMI S, Ferdousi M, Kalteniece A, Petropoulos IN, et al
    Corneal confocal microscopy identifies early and definite diabetic cardiac autonomic neuropathy.
    Diabetes Res Clin Pract. 2025;224:112172.
    PubMed         Abstract available
    
    
13. MANOS G, Apostolopoulos J, Read M, Cox M, et al
    Making Sense: Feasibility of an education program to Empower adults with type 1 diabetes to interpret CGM data.
    Diabetes Res Clin Pract. 2025;224:112171.
    PubMed         Abstract available
    
    
14. LACY ME, Smith AP, Hammerslag LR, Heier KR, et al
    Comparison of the association between COVID-19 and new onset diabetes in a regional and national dataset.
    Diabetes Res Clin Pract. 2025;224:112190.
    PubMed         Abstract available
    
    
15. MARTIN-SAN AGUSTIN R, Del Pino AC, Laguna Sanz AJ, Rossetti P, et al
    Impact of continuous moderate-intensity aerobic exercise on glycemic control according to different phases of the menstrual cycle in females with type 1 diabetes.
    Diabetes Res Clin Pract. 2025;224:112192.
    PubMed         Abstract available
    
    
16. JASER SS, Hamdan TA, Hilliard ME, Yi-Frazier JP, et al
    SCI - U: Validation of an updated Self-Care Inventory for contemporary diabetes management in adolescents with type 1 diabetes.
    Diabetes Res Clin Pract. 2025;224:112218.
    PubMed         Abstract available
    
    
17. FIGUEIREDO MOREIRA CF, Ferreira Peres WA, Silva do Nascimento Braga J, Proenca da Fonseca AC, et al
    Effect of vitamin D supplementation on glycemic control in children and adolescents with type 1 diabetes mellitus: Data from a controlled clinical trial.
    Diabetes Res Clin Pract. 2025;224:112210.
    PubMed         Abstract available
    
    
18. GARCIA-HERMOSO A, Huerta-Uribe N, Hormazabal-Aguayo I, Munoz-Pardeza J, et al
    Development and validation of a scale measuring perceived barriers to physical activity in Spanish for children and adolescents with type 1 diabetes: the Physical Activity Barriers Scale for pediatric type 1 diabetes (PABS-1) questionnaire.
    Diabetes Res Clin Pract. 2025;224:112223.
    PubMed         Abstract available
    
    
19. BONHOF GJ, Ziegler D, Sipola G, Wagner R, et al
    Diagnostic performance of graded tuning fork vibration thresholds as a stand-alone test and within clinical assessments of diabetic neuropathy.
    Diabetes Res Clin Pract. 2025;224:112224.
    PubMed         Abstract available
    
    
20. ELBARBARY NS, Khattab DA, Sultan BM, Rahman Ismail EA, et al
    Periodontal disease in adolescents with type 1 diabetes mellitus: A cross link between continuous glucose monitoring-derived metrics, caspase-3 levels, diabetic nephropathy and subclinical atherosclerosis.
    Diabetes Res Clin Pract. 2025;224:112234.
    PubMed         Abstract available
    
    
21. MESSINA MV, Pozzilli P, Zampetti S
    Paediatric screening in Italy as a gateway to secondary prevention in type 1 diabetes.
    Diabetes Res Clin Pract. 2025;224:112233.
    PubMed         Abstract available
    
    
22. HERMANNS N, Heinemann L, Kulzer B, Schafer A, et al
    Continuous glucose monitoring as equinox of nocturnal and daytime hypoglycaemia in type 1 diabetes: insights from the randomized controlled HypoDE trial.
    Diabetes Res Clin Pract. 2025;224:112228.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

23. HAI Y, Ma Q, Fang S, Bahramimehr F, et al
    High-Throughput Proteomics and Immunohistochemistry of Orbital Connective Tissue in Graves' Orbitopathy.
    J Clin Endocrinol Metab. 2025 May 21:dgaf299. doi: 10.1210.
    PubMed         Abstract available
    
    
24. WEBER DR, O'Brien KO, Ballester L, Rackovsky N, et al
    Greater urinary calcium excretion is associated with diminished bone accrual in youth with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Sep 20:dgae660. doi: 10.1210.
    PubMed         Abstract available
    
    
25. HUBER E, Singh T, Bunk M, Hebel M, et al
    Discrimination and precision of Continuous Glucose Monitoring in staging children with presymptomatic type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Oct 16:dgae691. doi: 10.1210.
    PubMed         Abstract available
    
    
26. YIN Q, Zhu T, Song D, Fang S, et al
    Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED.
    J Clin Endocrinol Metab. 2025;110:1537-1549.
    PubMed         Abstract available
    
    
27. KIM S, Subramanian S
    Approach to Lipid Management in the Patient with Diabetes.
    J Clin Endocrinol Metab. 2025 Jan 11:dgaf018. doi: 10.1210.
    PubMed         Abstract available
    
    
28. NIERVES LA, Lin TT, Moradian A, Shen Q, et al
    Biomarkers, Proteoforms, and Mass Spectrometry-based Assays for Diabetes Clinical Research.
    J Clin Endocrinol Metab. 2025 Mar 8:dgaf159. doi: 10.1210.
    PubMed         Abstract available
    
    
29. ONENGUT-GUMUSCU S, Concannon P, Akolkar B, Erlich HA, et al
    The Type 1 Diabetes Genetics Consortium (T1DGC).
    J Clin Endocrinol Metab. 2025 Mar 21:dgaf181. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Immunol

30. CHEN N, Wu J, Sun D, Kaplan HJ, et al
    Mice deficient of G-protein coupled receptor 3 (GPR3) developed severe experimental autoimmune uveitis (EAU) through increased effector T cell activities.
    J Immunol. 2025 May 17:vkaf099. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

31. INOUE Y, Fujii T, Kashu KY, Watanabe M, et al
    Associations between serum levels of alpha-calcitonin gene-related peptide and clinical features of neuromyelitis optica spectrum disorders.
    J Neuroimmunol. 2025;404:578615.
    PubMed         Abstract available
    
    
32. SANDWEISS AJ, Rosen J, Aduru C, Chandrasekar A, et al
    MOGAD optic neuritis after mild head/orbital trauma in six children.
    J Neuroimmunol. 2025;404:578605.
    PubMed         Abstract available
    
    
33. JAHANSOOZ JR, Kameoka AM, Shibuya J, Abramowitz J, et al
    Recurrent anti-NMDA receptor encephalitis in first-trimester pregnancy with initially antibody-negative CSF.
    J Neuroimmunol. 2025;404:578602.
    PubMed         Abstract available
    
    

    
    J Neurol

34. DAVIES L, Shehadeh R, Watkins WJ, Jolles S, et al
    Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis.
    J Neurol. 2025;272:415.
    PubMed         Abstract available
    
    
35. CAO S, Zhou X, Du J, Zhang J, et al
    Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD.
    J Neurol. 2025;272:406.
    PubMed         Abstract available
    
    
36. ZHANG Y, Li G, Su H, Liang Y, et al
    Effects of exercise on balance function in people with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials.
    J Neurol. 2025;272:405.
    PubMed         Abstract available
    
    
37. GERVASONI E, Torchio A, Bertoni R, Chieffo R, et al
    Beyond EDSS: multidomain impairments are detectable and associated with walking disorders in low-disabled people with multiple sclerosis.
    J Neurol. 2025;272:404.
    PubMed         Abstract available
    
    
38. WANG Z, Tan H, Huang W, Fan Y, et al
    Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in neuromyelitis optica spectrum disorder.
    J Neurol. 2025;272:403.
    PubMed         Abstract available
    
    

    
    Mult Scler

39. MARRIE RA, Maxwell CJ, Everett K, Zhu F, et al
    Health care use preceding pediatric multiple sclerosis: A population-based study from Ontario, Canada.
    Mult Scler. 2025 May 23:13524585251338745. doi: 10.1177/13524585251338745.
    PubMed         Abstract available
    
    
40. CHAN F, Berhanu D, Samadzadeh S, Francis A, et al
    Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD.
    Mult Scler. 2025;31:658-667.
    PubMed         Abstract available
    
    
41. LEE A, Iordanova RT, Smith JB, Li BH, et al
    Incidence and prevalence of neuromyelitis optica spectrum disorder in a contemporary, multi-ethnic cohort.
    Mult Scler. 2025;31:642-657.
    PubMed         Abstract available
    
    
42. FOX RJ, Cohan S, Mao-Draayer Y, Weinstock-Guttman B, et al
    Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study.
    Mult Scler. 2025;31:706-718.
    PubMed         Abstract available
    
    
43. GRESELIN M, Lu PJ, Mroczek M, Cerda-Fuertes N, et al
    AI-assisted identification of disability patterns within identical EDSS grades.
    Mult Scler. 2025;31:677-688.
    PubMed         Abstract available
    
    

    
    PLoS One

44. GUAN X, Liu W, Gao T, Jin W, et al
    Anti-beta2GPI/beta2GPI complex promotes thrombosis by activating the P2Y2/MAPKs pathway to increase human neutrophil peptides.
    PLoS One. 2025;20:e0322447.
    PubMed         Abstract available
    
    
45. OMER N, Wilczynski E, Zlotzover S, Helft C, et al
    Validation of a data-driven multicomponent T2 analysis for quantifying myelin content in the cuprizone mouse model of multiple sclerosis.
    PLoS One. 2025;20:e0323614.
    PubMed         Abstract available
    
    
46. YOUNG G, Nguyen VS, Howlett-Prieto Q, Abuaf AF, et al
    Validation of retroactively derived T1 relaxation values from 3D T1-weighted images with clinical and MRI measures of disability in multiple sclerosis.
    PLoS One. 2025;20:e0323898.
    PubMed         Abstract available
    
    
47. OZTURK HK, Slanar O, Michalickova D
    Safety and efficacy of antigen-specific therapeutic approaches for multiple sclerosis: Systematic review.
    PLoS One. 2025;20:e0320814.
    PubMed         Abstract available
    
    
48. LAI L, Wu C, Li X, Rong Y, et al
    Urinary MCP-1 and VCAM-1 as non-invasive biomarkers for the diagnosis and activity assessment of lupus nephritis.
    PLoS One. 2025;20:e0323334.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

49. GUPTA S, Arnab S, Nguyen KL, Reed M, et al
    Sex-chromosome complement and Activin-A shape the therapeutic potential of TNFR2 activation in a model of MS and CNP.
    Proc Natl Acad Sci U S A. 2025;122:e2426771122.
    PubMed         Abstract available
    
    
50. JENSEN LT, Fugger L
    Immune perturbation by the ileal microbiota in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2025;122:e2506777122.
    PubMed        
    
    

    
    Thyroid

51. ROZTOCIL E, Husain F, Patrick CC, Feldon SE, et al
    Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease.
    Thyroid. 2025 Apr 21. doi: 10.1089/thy.2024.0529.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.